Stimulation of cystine uptake by nitric oxide: regulation of endothelial cell glutathione levels

Hongfei Li, Zermeena M. Marshall, and A. Richard Whorton

Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Nitric oxide (NO) is known to produce some of its biological activity through modification of cellular thiols. Return of cellular thiols to their basal state requires the activity of the GSH redox cycle, suggesting important interactions between NO signaling and regulation of cellular redox status. Because continuous exposure to NO may lead to adaptive responses in cellular redox systems, we investigated the effects of NO on cellular GSH levels in vascular endothelial cells. Acute exposure (1 h) of cells to >1 mM S-nitroso-N-acetyl-penicillamine (SNAP) led to depletion of GSH. On the other hand, chronic exposure to lower concentrations of SNAP (<= 1 mM) led to a progressive increase in cytosolic GSH, reaching fourfold above basal by 16 h. The mechanism may involve an increase in GSH biosynthesis through effects on biosynthetic enzymes or through increased supply of cysteine, the limiting substrate. In this regard, we report that chronic exposure to SNAP led to a concentration-dependent increase in cystine uptake over a time course similar to that seen for elevation of GSH. The effect of SNAP on cystine uptake was inhibitable by either cycloheximide or actinomycin D, suggesting a requirement for both RNA and protein synthesis. Furthermore, uptake was Na+ independent and was blocked by extracellular glutamate. Extracellular glutamate also blocked SNAP-mediated elevation of cytosolic GSH. Finally, in a coculture model, NO produced by cytokine-pretreated RAW 264.7 cells increased both GSH levels and cystine uptake in naive endothelial cells. These findings strongly suggest that NO leads to adaptive induction of the x-c amino acid transport system, increased cystine uptake, and elevation of intracellular GSH levels.

cysteine; amino acid transport; nitrosative stress; oxidative stress


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

GLUTATHIONE is a critical intracellular reductant that functions in protecting cells from free radicals, reactive oxygen species, and toxic substances. The intracellular concentration of GSH is in the range of 1-10 mM in many cells and is maintained by controls on its biosynthesis. Several mechanisms are important. For example, the rate-limiting enzyme gamma -glutamylcysteine synthase is regulated by GSH levels (18, 26) and by oxidants (20) such that depletion of GSH or the presence of oxidants increases its activity. GSH synthesis is also dependent on the availability of the amino acid precursors glutamate, glycine, and cysteine (7, 8, 10, 18). Because glutamate and glycine occur at relatively high intracellular concentrations, cysteine availability largely determines GSH synthesis. Therefore, intracellular GSH levels are dependent on cysteine levels in the extracellular space and thus on transport of cysteine or cystine into cells.

A number of mechanisms are available for transport of cystine or cysteine equivalents (cysteinylglycine) into cells. Cysteine can be taken up directly via the Na+-dependent amino acid transport system called the ASC system (4, 14, 29). In many cells, this is a major route for supplying intracellular cysteine to maintain GSH levels. However, because cystine levels are generally higher than cysteine levels in extracellular fluids (and in cell culture media), mechanisms for cystine uptake are also crucial for GSH biosynthesis. Cystine is taken up by an amino acid transport system designated x-c, which is Na+ independent, inducible, and exhibits a high degree of specificity for cystine and glutamate (7, 14, 19, 27, 33). Once inside a cell, cystine is rapidly reduced to cysteine. In some cells, intracellular cysteine may result from the activity of gamma -glutamyl transpeptidase utilizing extracellular GSH and cystine as substrates (33).

Oxidant stress imposed by reactive oxygen species is known to increase GSH levels as part of an adaptive response (7, 8, 19, 27). Although regulation of gamma -glutamylcysteine synthase activity is certainly involved after acute exposure (18, 20, 26), oxidants also induce cystine uptake in some cells. For example, exposure of endothelial cells (7, 19), V79 cells (21), and macrophages (27) to agents that cause oxidant stress [H2O2, arsenite, diethyl maleate (DEM), hyperoxia, and cadmium] leads to increased activity of the x-c but not the ASC uptake system. Induction of the x-c system occurs over 6-12 h in endothelial cells (6) or V79 cells (21) exposed to arsenite, leading to a two- to threefold increase in GSH levels by 16 h.

Nitric oxide (NO) is well known to activate guanylate cyclase. In addition to this signaling role, NO is also known to interact with cellular redox systems, especially thiol groups. Thus NO exposure or synthesis may impose a nitrosative stress similar to that imposed by oxygen-derived species. Whether or not nitrosative stress produces adaptive responses in cells is not well studied. However, exposure of cells to NO protects them from apoptosis through induction of heat shock proteins (13) or caspase 3 (9), and NO is known to react with and modify cellular responses to oxygen-derived species (35, 36). Furthermore, others have reported increases in GSH in cells exposed to NO for 2 h (17), and recently, in preliminary experiments, we have observed that exogenous NO leads to accumulation of GSH over an extended time course. Because oxidative stress from oxygen-derived species promotes an increase in GSH biosynthesis by inducing cystine transport, we speculated that the accumulation of GSH in cells exposed to NO occurred via a similar mechanism. In the present study, we present data that show that NO leads to elevation of intracellular GSH in vascular endothelial cells through a mechanism that involves induction of cystine uptake. This adaptive response is potentially important in protecting cells from exposure to NO synthesized endogenously or NO produced in an inflammatory setting.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Materials. Fetal bovine serum (FBS) was obtained from HyClone (Logan, UT). All other cell culture reagents were from GIBCO (Grand Island, NY). Tissue culture plasticware was obtained from NUNC (Fisher Scientific, Raleigh, NC), and Costar coculture plates were from Corning (Alton, MA). S-nitroso-N-acetyl-penicillamine (SNAP) was from Research Biochemicals International (Natick, MA). L-[35S]cystine was obtained from DuPont NEN (Boston, MA). L-Cystine, glutamic acid, GSSG, glutathione reductase, DEM, NADPH, and N-acetyl-penicillamine were purchased from Sigma Chemical (St. Louis, MO). S-nitrosoglutathione (GSNO) was synthesized as previously described (23). Enhanced chemiluminescense (ECL) reagents were from Amersham Life Science (Arlington Heights, IL).

Cell culture. Vascular endothelial cells were isolated and grown in culture by established methods as previously described (25). Briefly, bovine aortic segments were cleaned and opened, and the endothelium was removed by scraping. Isolates were plated on collagen-coated tissue culture plasticware. Cells were grown in DMEM containing 10% FBS, 100 U/ml penicillin G sodium, 100 µg/ml streptomycin sulfate, and 250 ng/ml amphotericin B (complete DMEM) and incubated at 37°C in 7.5% CO2 in air. Cells were removed from flasks with trypsin-EDTA and seeded at 25% of confluent density into fresh flasks.

Cells from the mouse monocyte-macrophage cell line RAW 264.7 were grown in DMEM containing 10% FBS and antibiotic-antimycotic (see above) and incubated at 37°C in 7.5% CO2 in air. Cells were passaged by treatment with trypsin-EDTA.

Exposure to NO. Confluent monolayers of endothelial cells were treated with SNAP in complete serum-containing DMEM for various periods of time and washed with Hanks' balanced salt solution containing 10 mM HEPES (HBSS-HEPES; pH 7.4) before GSH measurements or measurement of cystine uptake. To determine the effect of NO produced by one cell on cystine uptake in neighboring endothelial cells, we employed a coculture model. In this model, RAW 264.7 cells were grown on the upper surface of the collagen-coated membrane of the transferable well insert of a six-well coculture tissue culture plate in complete DMEM. After reaching confluence, RAW 264.7 cells were induced to express the inducible isoform of NO synthase (iNOS) by incubating cells with a combination of 10 µg/ml lipopolysaccharide, 100 U/ml interferon-gamma , 1 ng/ml tumor necrosis factor-alpha , and 100 U/ml interleukin-1beta in DMEM containing 1% FBS for 24 h. Meanwhile, endothelial cells were grown to confluence on the bottom of collagen-coated wells in separate plates using DMEM as described above. To start a coculture experiment, inserts containing RAW 264.7 cells expressing iNOS were rinsed twice with fresh DMEM containing 1% FBS and then placed in wells containing confluent endothelial cells that had also been rinsed with fresh DMEM containing 1% FBS. Cells were coincubated for 24 h, after which endothelial extracts were prepared for glutathione measurement or endothelial cells were used to measure cystine uptake. Under these conditions, RAW 264.7 cells produced ~5.3 nmol NO · ml-1 · h-1.

Uptake assay. Cystine uptake was determined using [35S]cystine (6, 7). Confluent endothelial cell monolayers of cells treated with SNAP or cells from the coculture model were rinsed twice with warm HBSS-HEPES and incubated for 60 min in the same buffer in room air at 37°C. After two more rinses with HBSS-HEPES, the cells were incubated in 1 ml of buffer containing L-[35S]cystine (1 µCi/60 µM) in room air at 37°C for 10 min. After removal of the buffer, cells were rinsed four times with ice-cold HBSS-HEPES buffer containing 600 µM cystine. Cells were lysed in 1% Triton X-100 in HBSS-HEPES, and cystine uptake was measured by determining the amount of 35S in an aliquot of the lysate using a liquid scintillation counter. With these procedures, cystine uptake was linear for at least 20 min. In experiments in which the Na+ dependence of cystine uptake was determined, Li+ (as LiCl) was substituted for Na+.

Glutathione assay. Cells were rinsed twice with HBSS-HEPES and scraped into 0.5 ml of ice-cold 1 M perchloric acid containing 2 mM EDTA and extracted for 30 min on ice. After centrifugation at 2,000 g in a microcentrifuge, the acid extract was neutralized with 4 M KOH containing 0.6 M MOPS, and samples were centrifuged to remove the potassium perchlorate precipitate. Total glutathione levels (GSH and GSSG) were determined spectrophotometrically using the glutathione reductase-linked 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB) recycling assay (34). The assay conditions were 100 mM KPO4 (pH 7.0), 100 µM DTNB, 300 µM NADPH, and 0.2 U/ml glutathione reductase. Each assay was individually calibrated using known concentrations of GSH. All data were normalized per milligram of cellular protein. Protein concentrations were determined using the Bradford dye binding technique with BSA as a standard (3).

Immunoblot procedures. After incubation of RAW 264.7 cells with cytokines, cells on inserts were lysed with boiling sample buffer containing 63 mM Tris (pH 6.8), 10% glycerol, and 2% SDS. After sonication, an aliquot was removed for protein determination, and beta -mercaptoethanol was added to a final concentration of 5%. Extracts were boiled for 5 min at 100°C, and equivalent amounts of extract prepared from treated and untreated cells were loaded onto 8% SDS-polyacrylamide gels and resolved by SDS-PAGE. Proteins were transferred from the gel to a nitrocellulose membrane by electrophoretic elution in a buffer containing 25 mM Tris (pH 8.3), 130 mM glycine, 0.1% SDS, and 20% methanol for 12 h. Nonspecific binding sites on the membrane were blocked with 5% nonfat dry milk in 10 mM Tris (pH 7.5), 100 mM NaCl, and 0.1% Tween 20 at room temperature with agitation for 1 h. The blot was probed with an affinity-purified polyclonal anti-iNOS antibody raised against a 21-kDa protein fragment from the COOH-terminal region of mouse macrophage iNOS (Transduction Laboratories, Lexington, KY). The antibody was diluted 1:100,000 in blocking buffer and incubated with the membrane for 1 h at room temperature with agitation. The blot was washed five times with 10 mM Tris (pH 7.5), 100 mM NaCl, and 0.1% Tween 20 and incubated with agitation for 1 h with rabbit anti-mouse IgG conjugated to horseradish peroxidase, diluted 1:2,000 in blocking buffer. The blot was rinsed five times, exposed to ECL reagents according to the manufacturer's instructions, and exposed to film.

Statistical analysis. Group means were compared by one-way ANOVA and Student's t-test.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

In these studies, we examined the effects of nitrosative stress imposed by incubation of vascular endothelial cells with SNAP. SNAP decomposes slowly, presumably by homolytic decomposition to release NO. Metal ions, especially copper ions, and visible light are known to catalyze decomposition and may dramatically increase the rate of NO release (28). The half-life is thus dependent on the conditions. We determined the rate of decomposition of SNAP (measured as loss of the S-NO absorbance at 335 nm) incubated with confluent endothelial cells in DMEM containing 1% FBS under fluorescent light and found the half-life to be 4 h. When vascular endothelial cells were exposed to SNAP, two responses were seen. The nature of the response depended on the concentration of SNAP and on the length of exposure. Acute exposure (1 h) to concentrations from 1 to 10 mM led to a fall in intracellular glutathione (GSH and GSSG) concentrations (Fig. 1). The decline in GSH seen in response to a 1-h incubation with 5 mM SNAP was presumably the result of ~0.8 µmol/ml NO released into solution (based on the half-life). However, it is unlikely that the intracellular compartment is exposed to all of the NO released, since NO produced in the medium may diffuse into the atmosphere or may react with either O2 or metal ions both outside and within the cell. Furthermore, because NO itself does not react appreciably with cellular thiols, oxidation to more reactive species such as NO+ is likely responsible for the effects shown in Fig. 1. This acute response to NO exposure has been previously reported by us and others (5, 11, 13, 25).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   Effect of S-nitroso-N-acetyl-penicillamine (SNAP) on intracellular GSH levels. Confluent monolayers of vascular endothelial cells were incubated at 37°C with 0, 1, 5, or 10 mM SNAP for 1 h in DMEM (1 ml total volume) containing 10% serum and 1% antibiotics. Cells were rinsed and treated with perchloric acid to precipitate protein, and acid extracts were used to measure intracellular GSH + GSSG concentrations. Data are expressed as means ± SE in nmol GSH/mg protein and represent 3 similar independent experiments with triplicate observations in each experiment. * Significantly different from control, P < 0.05.

In contrast to these effects resulting from acute exposure to millimolar concentrations, chronic exposure to lower concentrations of SNAP (those that do not deplete GSH) led to a time-dependent elevation of intracellular GSH (Fig. 2). The increase in GSH was first evident at 6 h, continued to increase to about four times the control levels, and remained elevated for 16-18 h. The effect of SNAP on GSH levels was concentration dependent (Fig. 3), reaching a maximum at 1 mM. At higher concentrations (5 mM), cells appeared to be damaged (some were detached). Incubation with N-acetyl-penicillamine did not produce a similar increase in GSH. In fact, at higher concentrations (>= 1 mM N-acetyl-penicillamine), GSH levels were lower than those in untreated cells. Long-term incubation with other nitrosothiols (GSNO) also led to a rise in cytosolic GSH levels (Fig. 3B). In contrast to the effect of SNAP, the effect of GSNO was still evident at 5 mM, perhaps due to the longer half-life of GSNO (slower NO release) and lack of overt signs of injury (no detachment).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Time course for SNAP-induced elevation of GSH levels. Confluent monolayers of vascular endothelial cells were treated with 1 mM SNAP in DMEM (2 ml) containing 10% serum and 1% antibiotics at 37°C. Incubations were stopped at times indicated, cells were rinsed and treated with perchloric acid to precipitate protein, and acid extracts were used to measure intracellular GSH + GSSG. Data are expressed as means ± SE in nmol GSH/mg protein and represent 3 similar independent experiments with triplicate observations in each experiment.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of S-nitrosothiols on GSH levels in endothelial cells. Confluent monolayers of vascular endothelial cells were incubated in DMEM containing 1% fetal bovine serum (FBS) and 1% antibiotics with various concentrations of either SNAP or S-nitrosoglutathione (GSNO) for 16 h at 37°C. Cells were then rinsed with ice-cold Hanks' balanced salt solution-10 mM HEPES (HBSS-HEPES; pH 7.4) and treated with perchloric acid, and acid extracts were used to measure intracellular GSH + GSSG. A: incubation with SNAP or N-acetyl-penicillamine (NAP). B: incubation with GSNO or GSSG. Data are expressed as means ± SE in nmol GSH/mg protein; n = 4 measurements.

Others have seen increases in intracellular GSH levels after exposing cells to arsenite, DEM, or H2O2 (6, 7, 19, 21). In each case, the rise in GSH was dependent on induction of cystine transport. Untreated confluent monolayers of bovine aortic endothelial cells transport cystine at a nearly linear rate (180 pmol · 106 cells-1 · 10 min-1) for 20 min (Fig. 4A). As reported by others, when cells were incubated for 24 h with the thiol-modifying agent DEM (125 µM), the rate was significantly increased (Fig. 4A). Similarly, when endothelial cells were incubated for 24 h with SNAP, we observed a concentration-dependent increase in the rate of cystine uptake (Fig. 4B). Incubation with 1 mM SNAP increased the rate of cystine uptake by approximately twofold. These data are the first demonstration that NO or its redox derivatives increase cystine uptake in endothelial cells.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4.   Stimulation of cystine uptake by SNAP. Confluent monolayers of endothelial cells were treated with SNAP for 24 h in DMEM (2 ml) containing 10% serum and 1% antibiotics at 37°C. To measure cystine uptake, cells were rinsed and incubated in HBSS-HEPES containing 1 µCi [35S]cystine (60 µM) for 10 min. After times indicated, cells were rinsed 4 times with ice-cold HBSS-HEPES buffer containing 600 µM cystine and lysed in 1% Triton X-100 in HBSS-HEPES, and cystine uptake was measured by determining amount of 35S in an aliquot of lysate using a liquid scintillation counter. A: time course of cystine uptake in control and with diethyl maleate (DEM; 125 µM). Data are expressed as counts/min (cpm) of [35S]cystine taken up into cells per microgram of protein (means ± SE, n = 6). B: cystine uptake after 24-h incubation of endothelial cells with SNAP at indicated concentrations. Data are expressed as multiples of control value and represent 3 similar independent experiments with triplicate observations in each experiment. Basal uptake was 71.17 ± 2.31 cpm · µg protein-1 · 10 min-1 (mean ± SE), which is equivalent to 370 pmol · 106 cells-1 · 10 min-1. * Significantly different from control, P < 0.05.

In subsequent experiments, we examined the mechanisms for increased uptake and characterized the transport system. The increase in cystine transport activity was observed as early as 4 h after exposure to 1 mM SNAP and continued to be elevated for at least 24 h (Fig. 5). The mechanism for increased cystine uptake appeared to require both RNA and protein synthesis, since either actinomycin D or cycloheximide blocked the response to SNAP (Fig. 6). As such, the effect of SNAP appears to be the induction of expression of a cystine transport system. The time course for NO-mediated effects on cystine uptake is similar to that seen for NO-stimulated increases in cellular GSH reported in Fig. 2 and is consistent with a role for induced cystine uptake in the elevation in GSH.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   Time course for SNAP-stimulated cystine uptake. Confluent monolayers of endothelial cells were treated with 1 mM SNAP in DMEM (2 ml) containing 10% serum and 1% antibiotics at 37°C. After times indicated, cells were rinsed twice with HBSS-HEPES and cystine uptake was determined as described in Fig. 4. Data are expressed as cpm [35S]cystine/µg protein (means ± SE, n = 6).


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 6.   Effect of cycloheximide or actinomycin D on SNAP-stimulated cystine uptake. Confluent endothelial cells were incubated in buffer containing 1 mM SNAP and either cycloheximide (CHX; 1 µg/ml) or actinomycin D (AD; 2.5 µg/ml) for 8 h in DMEM containing 10% serum and 1% antibiotics at 37°C. Cells were then rinsed as described in Fig. 4, and cystine uptake was determined. Data are expressed as multiples of control value (means ± SE, n = 6). Control value for this experiment was (mean ± SE) 29.3 ± 0.5 cpm · µg protein-1 · 10 min-1, which is equivalent to ~173 pmol · 106 cells-1 · 10 min-1. * Significantly different from control, P < 0.001. + Significantly different from SNAP-treated group, P < 0.001.

We further characterized SNAP-induced cystine uptake by examining the Na+ dependence and effect of glutamate. As shown in Fig. 7, substituting Li+ for Na+ in the medium had little effect on the extent of cystine uptake (compared with control without Na+) induced following a 24-h exposure to SNAP, suggesting that stimulated uptake is primarily Na+ independent. Na+-independent cystine uptake is characteristic of the x-c system. The cystine transport system is also known to have a high affinity for glutamate and exchanges intracellular glutamate for extracellular cystine. Addition of glutamate to the extracellular medium would be expected to effectively block cystine transport. As shown in Fig. 8, this is indeed the case in endothelial cells, since addition of 5 mM glutamate to the medium completely blocked the increase in cystine transport induced by a 24-h incubation with 1 mM SNAP. Others have shown that gamma -glutamyl transpeptidase, which is also inhibited by glutamate and is Na+ independent, participates in cystine uptake in some cells (33). We have examined the potential role of this enzyme by investigating the effects of acivicin, a specific gamma -glutamyl transpeptidase inhibitor, on SNAP-induced cystine uptake. Acivicin (5 mM) did not significantly alter cystine uptake following treatment of cells with SNAP (Fig. 9), suggesting that gamma -glutamyl transpeptidase is not responsible for the glutamate-sensitive cystine uptake we have measured. Taken together, these data strongly suggest that NO increases cystine uptake by inducing some critical component of the x-c transport system.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of Na+ on SNAP-induced cystine uptake. Confluent endothelial cells were treated with 1 mM SNAP in DMEM containing 10% serum and 1% antibiotics at 37°C as described in Fig. 4. After 24 h, cells were rinsed and cystine uptake was measured in Na+-complete buffer or buffer in which Li+ replaced Na+. Data are expressed as cpm [35S]cystine/µg protein (means ± SE, n = 6). * Significantly different from paired control (Cont), P < 0.05. + Significantly different from Na+-free control, P < 0.05.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of glutamate (GLU) on SNAP-induced cystine uptake. Confluent endothelial cells were treated with SNAP (1 mM) in DMEM containing 10% serum and 1% antibiotics at 37°C as described in Fig. 4. Cystine uptake was determined in presence or absence of glutamate (5 mM) in uptake assay buffer. Data are expressed as multiples of control (means ± SE, n = 6). * Significantly different from control, P < 0.001. + Significantly different from SNAP-treated group, P < 0.001.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 9.   Effect of acivicin on SNAP-induced cystine uptake. Confluent endothelial cells were treated with SNAP (1 mM) in DMEM containing 10% serum and 1% antibiotics at 37°C as described in Fig. 4. Cystine uptake was determined in presence or absence of acivicin (5 mM) added to uptake assay buffer. Data are expressed as multiples of control (means ± SE, n = 3). * Significantly different from control, P < 0.001.

As shown above, exposure to low levels of SNAP (<= 1 mM) increased GSH levels over a time course similar to that seen for induction of the cystine transport system. This suggests that increased cystine uptake participates in increased intracellular GSH levels. In the following experiments, we explored this possibility using glutamate in the medium bathing cells to block the newly expressed x-c uptake system. As shown in Fig. 10, addition of 5 mM glutamate to the medium completely prevented the SNAP-induced increase in intracellular GSH, providing strong evidence that cystine uptake played at least a partial role in elevation of GSH levels.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 10.   Effects of glutamate on increase in intracellular GSH stimulated by SNAP. Confluent endothelial cells were treated with 1 mM SNAP, 1 mM SNAP + 5 mM glutamate, or 5 mM glutamate alone for 17 h in DMEM containing 10% serum and 1% antibiotics at 37°C. Data are expressed as means ± SE in nmol GSH/mg protein (n = 6). * Significantly different from control, P < 0.05. + Significantly different from SNAP-treated group, P < 0.05.

Finally, we determined whether NO produced by one cell type could affect GSH levels and cystine uptake in a neighboring cell. To examine this, we used RAW 264.7 rat monocytes grown on the membrane insert of a Transwell apparatus. These cells were pretreated with a cytokine mixture to induce iNOS. We have shown in other studies that the combination of endotoxin and interferon-gamma used in these studies leads to expression of iNOS within 4 h. Levels of protein expression reached maximal levels by ~24 h and remained elevated for at least 48 h (Fig. 11A). RAW 264.7 cells treated in this manner synthesized NO at a linear rate (5.3 nmol · ml-1 · h-1 · insert-1). The inserts were rinsed and then placed in plates in which endothelial cells had been grown to confluence on the bottom of the well. The distance separating the two cell types was ~1 mm in the coculture apparatus, necessitating diffusion of NO (or some NO-related product) produced by the RAW 264.7 cells over this distance to affect the endothelial cell monolayer. As shown in Fig. 11B, RAW 264.7 cells producing NO increased GSH levels in the endothelial cell monolayer and induced cystine uptake in these cells (Fig. 11C). Addition of aminoguanidine to inhibit iNOS during the coincubation of RAW 264.7 cells with endothelial cells prevented both the increase in GSH levels and induction of cystine uptake (Fig. 11, B and C). Aminoguanidine has no effect on SNAP-induced cystine uptake (data not shown). These data suggest that NO produced endogenously by one cell type may induce cystine transport and elevate GSH levels in neighboring cells.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 11.   Effect of NO production by RAW 264.7 cells on endothelial cell (EC) cystine uptake and intracellular GSH content. A: RAW 264.7 cells were preincubated for times indicated in DMEM containing 1% FBS and 1% antibiotics in presence or absence of 10 µg/ml lipopolysaccharide, 100 U/ml interferon-gamma , 1 ng/ml tumor necrosis factor-alpha , and 100 U/ml interleukin-1. Cells were rinsed with HBSS-HEPES and scraped into sample buffer as described. After resolution of proteins by SDS-PAGE and transfer to nitrocellulose, inducible NO synthase (iNOS) was visualized using a specific iNOS antibody. B and C: confluent EC were coincubated for 20 h in DMEM containing 10% serum and 1% antibiotics with RAW 264.7 cells that had been induced to express iNOS. EC were rinsed, and either extracts were prepared as described in Fig. 2 and used to determine GSH + GSSG levels (B) or, in separate experiments, EC were used to determine cystine uptake as described in Fig. 4 (C). In some experiments, 4 mM aminoguanidine (AG) was added to DMEM during coincubation to inhibit iNOS in RAW 264.7 cells. Data are expressed as means ± SE for triplicate determinations. * Significantly different from control, P < 0.05.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

NO is thought to regulate cellular function by interacting with critical thiols, leading to formation of both protein and small-molecular-weight nitrosothiols (1, 12, 30, 31). This mechanism has been proposed to be involved in NO-mediated activation of p21ras (15) and Ca+-dependent K+ channels (2), inactivation of caspases (9, 22), and regulation of ryanodine receptor activity (32, 37). In addition, acute exposure of cells to NO is associated with a transient decline in cellular GSH levels (5, 11, 25), presumably due to conversion of GSH to GSNO (5). It should be pointed out that these effects are not mediated by NO directly, since NO is a weak oxidant (1, 31). Rather, other redox forms, especially NO+ or species with NO+-like activity, produced through reaction of NO with transition metal ions, heme iron, or molecular oxygen are proposed to be intermediates (1, 31). These reactive NO-derived species are potent oxidants and pose a nitrosative stress to cells by compromising thiol redox status. In this regard, the GSH redox cycle has been shown to be an important protective mechanism that rapidly reverses NO-mediated protein modification and GSH depletion. For example, we have shown that the GSH redox cycle is required for reversal of NO-mediated glyceraldehyde-3-phosphate dehydrogenase inhibition in intact cells (23, 24) and in the recovery of GSH levels in cells exposed to exogenous sources of NO (25). In fact, both glutathione reductase and GSH levels are critical and necessary for restoring the native reduced protein thiol (24, 25). Through this mechanism, the GSH redox cycle is likely important in regulating cellular signaling mechanisms used by NO and provides a mechanism for restoring the basal state after proteins are modified (25). Similarly, the GSH redox cycle protects cells from oxidative stress imposed by oxygen-derived species. Chronic exposure of cells to oxidants leads to an array of adaptive responses. Given the importance of the GSH redox cycle, it is not surprising that one important component of the adaptive response is elevation of intracellular GSH levels. In many cells, this has been shown to occur through a mechanism that involves induction of cystine transport (7, 14, 27, 33). Because it is possible that cells respond to nitrosative and oxidative stress in similar ways, we have examined the effects of NO on cellular GSH levels and shown for the first time that NO, like reactive oxygen species, leads to an adaptive increase in GSH though a mechanism that, at least in part, requires induction of cystine transport.

Although acute exposure to NO leads to GSH depletion, chronic exposure leads to elevation of cellular GSH. In the present study, we show that 1 h of incubation with 5 mM SNAP leads to a 40% fall in GSH. Similar reductions in GSH levels have been reported by us and others in cells exposed to a variety of NO donors, including GSNO and spermine NO (25). In one study, it was suggested that the rapid fall in GSH in cells exposed to NO resulted from conversion of GSH to GSNO intracellularly (5). In this report, GSNO was identified as the NaBH4-reducible component of cellular extracts. In recent work by us (25), we report that GSNO and spermine deplete GSH in endothelial cells by promoting rapid formation of glutathionyl protein mixed disulfides. Because protein mixed disulfides are rapidly reduced by NaBH4 to release free GSH, it seems likely that the presence of these mixed disulfides can account for GSNO identified previously by others (5) and is the likely explanation for the fall in GSH reported in the present study.

In early experiments, we had observed that, after the initial decline in GSH, levels recover and begin to exceed the concentrations present in control cells. The extent of the initial decline is concentration dependent such that low concentrations of NO donor (<= 1 mM SNAP in the present study) lead to a rise in GSH without evidence of depletion. The increase in GSH was significant by 6 h. Several mechanisms may be involved in elevation of cellular GSH levels. These include increased biosynthesis of GSH or inhibition of GSH export. We have not observed any measurable GSH export from our endothelial cells and thus can rule out this mechanism, leaving us with the possibility that GSH biosynthesis is increased. GSH biosynthesis is dependent on the activity of the rate-limiting enzyme, gamma -glutamylcysteine synthetase, and the availability of cysteine (18, 26). The activity of gamma -glutamylcysteine synthetase is regulated by GSH, which competes with glutamate at the glutamate binding site in the catalytic domain and serves as a potent inhibitor of the enzyme. As levels of intracellular GSH fall due to mixed disulfide formation, conjugation, or export, gamma -glutamylcysteine synthetase is activated. GSH also appears to maintain inhibition of the enzyme by keeping an allosteric thiol reduced (20). However, because GSH depletion is not necessarily seen in cells in which GSH levels rise and because GSH levels are above control levels for an extended period, GSH depletion and subsequent activation of gamma -glutamylcysteine synthetase seems to be an unlikely explanation for increased biosynthesis. Direct effects of NO redox species on gamma -glutamylcysteine synthetase have not been documented, although NO appears to induce the expression of this enzyme in lung epithelial cells (16). Possibly this ability to increase levels of enzyme protein may explain the increase in GSH. However, data showing that the NO-induced increase in GSH is inhibitable by extracellular glutamate, a competitive inhibitor of cystine uptake, suggest that induction of the x-c transport system is quantitatively more important.

Supply of intracellular cysteine is known to limit GSH synthesis in many cases (7, 8, 10, 18). Cysteine itself is transported by the ASC amino acid transport system (4, 14, 29). This uptake mechanism is Na+ dependent and has a high capacity for cysteine transport (4, 14, 29). However, cysteine is oxidized to cystine outside cells, and cystine levels are generally higher than cysteine levels in the extracellular environment. Thus mechanisms for cystine uptake are important in maintaining intracellular GSH levels. A specific transport system designated x-c, which is Na+ independent and exchanges extracellular cystine for intracellular glutamate, has been described in a number of cells (7, 14, 19, 27, 33). Although the individual components have not been identified, this uptake system has been demonstrated to be activated by oxidant stress, sulfhydryl modifying reagents, arsenite, and cadmium in vascular endothelial cells, macrophages, and smooth muscle cells (7, 14, 19, 27, 33). The increase in cystine uptake stimulated by NO requires RNA and protein synthesis, becomes evident by ~6 h, and remains elevated for at least 24 h. This time course is consistent with the increase in GSH levels seen in cells exposed to SNAP. Although it had been suggested that depletion of GSH is involved in stimulation of cystine uptake (19), the effect we report with NO occurs in the absence of a detectable fall in cellular GSH levels. NO induction of cystine uptake appears to be mediated by the x-c transport system, since it is Na+ independent and inhibitable by extracellular glutamate.

In some cells, gamma -glutamyl transpeptidase may also participate in cysteine uptake. This protein is a cell surface enzyme that forms gamma -glutamyl amino acids (gamma -glutamylcysteine for example) and transports them into the cell, where cysteine may be released by peptidases. In studies with pancreatic duct cells (33), cystine uptake was found to be mediated by both the x-c transport system and gamma -glutamyl transpeptidase (which accounted for 40-50% of cystine uptake). Uptake by this gamma -glutamyl transpeptidase is also Na+ independent and inhibitable by glutamate. However, because gamma -glutamyl transpeptidase is specifically blocked by acivicin, this compound can be used to distinguish between the two possibilities. In our studies, acivicin had no effect on NO-induced cystine uptake, suggesting that in endothelial cells induction of the x-c system is the primary mechanism. Furthermore, as mentioned above, induction of cystine uptake by NO fully explains the increase in cellular GSH levels stimulated by NO, since extracellular glutamate completely prevented this effect, and suggests the requirement of the x-c system.

Induction of cystine uptake and elevation of intracellular GSH by NO donors suggest that NO produced by one cell might alter GSH metabolism in a neighboring cell. In our studies, NO produced by rat monocytes increased GSH levels and cystine uptake in endothelial cells after 20 h of coculture. This is important for several reasons. First, it suggests that endogenous NO production can induce cystine uptake and elevate GSH levels in cells. It also suggests that NO production by one cell can mediate adaptive responses in neighboring cells. Thus, in a setting where iNOS is induced and produces NO over an extended period, cells adapt by increasing their GSH levels and ability to reverse NO-mediated changes in cellular thiols (25). This is likely to be an important mechanism whereby tissue cells resist the potentially damaging effects of NO produced during inflammation.


    ACKNOWLEDGEMENTS

This work was supported by National Heart, Lung, and Blood Institute Grants HL-54149, HL-42444, and HL-51183.


    FOOTNOTES

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.

Address for reprint requests and other correspondence: A. R. Whorton, C138B Levine Science Research Center, Dept. of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710 (E-mail: awho{at}duke.edu).

Received 31 August 1998; accepted in final form 18 December 1998.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Arnelle, D. R., and J. S. Stamler. NO+, NO ·, NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch. Biochem. Biophys. 318: 279-285, 1995[Medline].

2.   Bolotina, V. M., S. Najibi, J. J. Palacino, P. J. Pagano, and R. A. Cohen. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368: 850-853, 1994[Medline].

3.   Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976[Medline].

4.   Bukowski, D. M., S. M. Deneke, R. A. Lawrence, and S. G. Jenkinson. A noninducible cystine transport system in rat alveolar type II cells. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L21-L26, 1995[Abstract/Free Full Text].

5.   Clancy, R. M., D. Levartovsky, J. Leszczynska-Piziak, J. Yegudin, and S. B. Abramson. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophiles: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc. Natl. Acad. Sci. USA 91: 3680-3684, 1994[Abstract].

6.   Deneke, S. M. Induction of cystine transport in bovine pulmonary endothelial cells by sodium arsenite. Biochim. Biophys. Acta 1109: 127-131, 1992[Medline].

7.   Deneke, S. M., D. F. Baxter, D. T. Phelps, and B. L. Fanburg. Increase in endothelial cell glutathione and precursor amino acid uptake by diethyl maleate and hypoxia. Am. J. Physiol. 257 (Lung Cell. Mol. Physiol. 1): L265-L271, 1989[Abstract/Free Full Text].

8.   Deneke, S. M., and B. L. Fanburg. Regulation of cellular glutathione. Am. J. Physiol. 257 (Lung Cell. Mol. Physiol. 1): L163-L173, 1989[Abstract/Free Full Text].

9.   Dimmeler, S., J. Haendeler, M. Nehls, and A. M. Zeiher. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta -converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185: 601-607, 1997[Abstract/Free Full Text].

10.   Hanigan, M. H., and W. A. Ricketts. Extracellular glutathione is a source of cysteine for cells that express gamma-glutamyl transpeptidase. Biochemistry 32: 6302-6306, 1993[Medline].

11.   Hothersall, J. S., F. Q. Cunha, G. H. Neild, and A. A. Norohna-Duthra. Induction of nitric oxide synthesis in J774 cells lowers intracellular glutathione: effect of modulated glutathione redox status on nitric oxide. Biochem. J. 322: 477-481, 1997[Medline].

12.   Jia, L., C. Bonaventura, J. Bonaventura, and J. S. Stamler. S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380: 221-226, 1996[Medline].

13.   Kim, Y. M., M. E. de Vera, S. C. Watkins, and T. R. Billiar. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha -induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272: 1402-1411, 1997[Abstract/Free Full Text].

14.   Knickelbein, R. G., T. Seres, G. Lam, R. B. Johnston, Jr., and J. B. Warshaw. Characterization of multiple cysteine and cystine transporters in rat alveolar type II cells. Am. J. Physiol. 273 (Lung Cell. Mol. Physiol. 17): L1147-L1155, 1997[Abstract/Free Full Text].

15.   Lander, H. M., J. S. Ogiste, K. K. Teng, and A. Novogrodsky. p21ras as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270: 21195-21198, 1997[Abstract/Free Full Text].

16.   Liu, R.-M., H. Hu, T. W. Robison, and H. J. Forman. Differential enhancement of gamma-glutamyl transpeptidase and gamma-glutamylcysteine synthetase by tert-butylhydroquinone in rat lung epithelial L2 cells. Am. J. Respir. Cell Mol. Biol. 14: 186-191, 1996[Abstract].

17.   Luperchio, S., S. Tamir, and S. R. Tannenbaum. NO-induced oxidative stress and glutathione metabolism in rodent and human cells. Free Radic. Biol. Med. 21: 513-519, 1996[Medline].

18.   Meister, A. Glutathione metabolism. Methods Enzymol. 251: 3-7, 1995[Medline].

19.   Miura, K., T. Ishii, Y. Sugita, and S. Bannai. Cystine uptake and glutathione levels in endothelial cells exposed to oxidative stress. Am. J. Physiol. 262 (Cell Physiol. 31): C50-C58, 1992[Abstract/Free Full Text].

20.   Ochi, T. Hydrogen peroxide increases the activity of gamma-glutamylcysteine synthetase in cultured Chinese hamster V79 cells. Arch. Toxicol. 70: 96-103, 1995[Medline].

21.   Ochi, T. Arsenic compound-induced increases in glutathione levels in cultured hamster V79 cells and mechanisms associated with changes in gamma -glutamylcysteine synthase activity, cystine uptake and utilization of cysteine. Arch. Toxicol. 71: 730-740, 1997[Medline].

22.   Ogura, T., M. Tatemichi, and H. Esumi. Nitric oxide inhibits CPP-32-like activity under redox regulation. Biochem. Biophys. Res. Commun. 236: 365-369, 1997[Medline].

23.   Padgett, C. M., and A. R. Whorton. S-nitrosoglutathione reversibly inhibits GAPDH by S-nitrosylation. Am. J. Physiol. 269 (Cell Physiol. 38): C739-C749, 1995[Abstract].

24.   Padgett, C. M., and A. R. Whorton. Glutathione redox cycle regulates nitric oxide-mediated glyceraldehyde-3-phosphate dehydrogenase inhibition. Am. J. Physiol. 272 (Cell Physiol. 41): C99-C108, 1997[Abstract/Free Full Text].

25.   Padgett, C. M., and A. R. Whorton. Cellular responses to nitric oxide: role of protein S-thiolation/dethiolation. Arch. Biochem. Biophys. 358: 232-242, 1998[Medline].

26.   Richman, P. G., and A. Meister. Regulation of gamma-glutamylcysteine synthetase by non-allosteric feedback inhibition by glutathione. J. Biol. Chem. 250: 1422-1426, 1975[Abstract].

27.   Sato, H., Y. Takenaka, K. Fujiwara, M. Yamaguchi, K. Abe, and S. Bannai. Increase in cystine transport activity and glutathione level in mouse peritoneal macrophages exposed to oxidized low-density lipoprotein. Biochem. Biophys. Res. Commun. 215: 154-159, 1995[Medline].

28.   Singh, R. J., N. Hogg, J. Joseph, and B. Kalyanaraman. Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem. 271: 18596-18603, 1996[Abstract/Free Full Text].

29.   Souba, W. W., and A. J. Pacitti. How amino acids get into cells: mechanisms, models, menus, and mediators. JPEN J. Parenter. Enteral Nutr. 16: 569-578, 1992[Abstract].

30.   Stamler, J. S., L. Jia, J. P. Eu, T. J. McMahon, I. T. Demchenko, J. Bonaventura, K. Gernert, and C. A. Piantadosi. Blood flow regulation by nitrosohemoglobin in the physiological oxygen gradient. Science 276: 2034-2037, 1997[Abstract/Free Full Text].

31.   Stamler, J. S., D. J. Singel, and J. Loscalzo. Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902, 1992[Medline].

32.   Stoyanovsky, D., T. Murphy, P. R. Anno, Y. M. Kim, and G. Salama. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21: 19-29, 1997[Medline].

33.   Sweiry, J. H., J. Sastre, J. Vina, H. P. Elsasser, and G. E. Mann. A role for gamma -glutamyl transpeptidase and the amino acid transport system x-c in cystine transport by a human pancreatic duct cell line. J. Physiol. (Lond.) 485: 167-177, 1995[Abstract].

34.   Tietze, F. Enyzmic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal. Biochem. 27: 502-522, 1969[Medline].

35.   Wink, D. A., J. A. Cook, R. Pacelli, W. DeGraff, J. Gamson, J. Liebmann, M. C. Krishna, and J. B. Mitchell. The effects of various nitric oxide-donor agents on hydrogen peroxidemediated toxicity: a direct correlation between nitric oxide formation and protection. Arch. Biochem. Biophys. 331: 241-248, 1996[Medline].

36.   Wink, D. A., J. A. Cook, R. Pacelli, J. Liebmann, M. C. Krishna, and J. B. Mitchell. Nitric oxide (NO) protects against cellular damage by reactive oxygen species. Toxicol. Lett. 82/83: 221-226, 1995.

37.   Xu, L., J. P. Eu, G. Meissner, and J. S. Stamler. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279: 234-237, 1998[Abstract/Free Full Text].


Am J Physiol Cell Physiol 276(4):C803-C811
0002-9513/99 $5.00 Copyright © 1999 the American Physiological Society